These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36970214)

  • 1. HBXIP blocks myosin-IIA assembly by phosphorylating and interacting with NMHC-IIA in breast cancer metastasis.
    Zhang L; Zhou X; Liu B; Shi X; Li X; Xu F; Fu X; Wang X; Ye K; Jin T; Sun H; Li Q; Zhang W; Ye L
    Acta Pharm Sin B; 2023 Mar; 13(3):1053-1070. PubMed ID: 36970214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYBPH inhibits NM IIA assembly via direct interaction with NMHC IIA and reduces cell motility.
    Hosono Y; Usukura J; Yamaguchi T; Yanagisawa K; Suzuki M; Takahashi T
    Biochem Biophys Res Commun; 2012 Nov; 428(1):173-8. PubMed ID: 23068101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myosin-IIA heavy chain phosphorylation on S1943 regulates tumor metastasis.
    Norwood Toro LE; Wang Y; Condeelis JS; Jones JG; Backer JM; Bresnick AR
    Exp Cell Res; 2018 Sep; 370(2):273-282. PubMed ID: 29953877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The actomyosin network is influenced by NMHC IIA and regulated by Crp
    Cao Y; Lei Y; Luo Y; Tan T; Du B; Zheng Y; Sun L; Liang Q
    Exp Cell Res; 2018 Dec; 373(1-2):119-131. PubMed ID: 30336116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Overexpression of NMHC IIA Promoted Invasion and Metastasis of Nasopharyngeal Carcinoma Cells.
    Xiong D; Chen D; Liu D; Wu W; Dou X; Ji X; Li J; Zhang X
    J Cancer; 2021; 12(14):4218-4228. PubMed ID: 34093822
    [No Abstract]   [Full Text] [Related]  

  • 6. The nuclear import of oncoprotein hepatitis B X-interacting protein depends on interacting with c-Fos and phosphorylation of both proteins in breast cancer cells.
    Zhang Y; Zhao Y; Li H; Li Y; Cai X; Shen Y; Shi H; Li L; Liu Q; Zhang X; Ye L
    J Biol Chem; 2013 Jun; 288(26):18961-74. PubMed ID: 23667255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oncoprotein hepatitis B X-interacting protein promotes the migration of ovarian cancer cells through the upregulation of S-phase kinase-associated protein 2 by Sp1.
    Xu F; Zhu X; Han T; You X; Liu F; Ye L; Zhang X; Wang X; Yao Y
    Int J Oncol; 2014 Jul; 45(1):255-63. PubMed ID: 24788380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1.
    Arii J; Goto H; Suenaga T; Oyama M; Kozuka-Hata H; Imai T; Minowa A; Akashi H; Arase H; Kawaoka Y; Kawaguchi Y
    Nature; 2010 Oct; 467(7317):859-62. PubMed ID: 20944748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oncoprotein HBXIP up-regulates FGF4 through activating transcriptional factor Sp1 to promote the migration of breast cancer cells.
    Shi H; Li Y; Feng G; Li L; Fang R; Wang Z; Qu J; Ding P; Zhang X; Ye L
    Biochem Biophys Res Commun; 2016 Feb; 471(1):89-94. PubMed ID: 26828265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonmuscle myosin heavy chain IIb mediates herpes simplex virus 1 entry.
    Arii J; Hirohata Y; Kato A; Kawaguchi Y
    J Virol; 2015 Feb; 89(3):1879-88. PubMed ID: 25428876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonmuscle Myosin Heavy Chain IIA Recognizes Sialic Acids on Sialylated RNA Viruses To Suppress Proinflammatory Responses via the DAP12-Syk Pathway.
    Liu Y; Li R; Chen XX; Zhi Y; Deng R; Zhou EM; Qiao S; Zhang G
    mBio; 2019 May; 10(3):. PubMed ID: 31064828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oncoprotein HBXIP upregulates Lin28B via activating TF II D to promote proliferation of breast cancer cells.
    Liu Q; Bai X; Li H; Zhang Y; Zhao Y; Zhang X; Ye L
    Int J Cancer; 2013 Sep; 133(6):1310-22. PubMed ID: 23494474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncoprotein HBXIP Modulates Abnormal Lipid Metabolism and Growth of Breast Cancer Cells by Activating the LXRs/SREBP-1c/FAS Signaling Cascade.
    Zhao Y; Li H; Zhang Y; Li L; Fang R; Li Y; Liu Q; Zhang W; Qiu L; Liu F; Zhang X; Ye L
    Cancer Res; 2016 Aug; 76(16):4696-707. PubMed ID: 26980761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oncoprotein HBXIP activates transcriptional coregulatory protein LMO4 via Sp1 to promote proliferation of breast cancer cells.
    Yue L; Li L; Liu F; Hu N; Zhang W; Bai X; Li Y; Zhang Y; Fu L; Zhang X; Ye L
    Carcinogenesis; 2013 Apr; 34(4):927-35. PubMed ID: 23291272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The oncoprotein HBXIP promotes human breast cancer growth through down-regulating p53 via miR-18b/MDM2 and pAKT/MDM2 pathways.
    Li H; Wang Z; Jiang M; Fang RP; Shi H; Shen Y; Cai XL; Liu Q; Ye K; Fan SJ; Zhang WY; Ye LH
    Acta Pharmacol Sin; 2018 Nov; 39(11):1787-1796. PubMed ID: 30181579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The collagen receptor DDR1 regulates cell spreading and motility by associating with myosin IIA.
    Huang Y; Arora P; McCulloch CA; Vogel WF
    J Cell Sci; 2009 May; 122(Pt 10):1637-46. PubMed ID: 19401332
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Yang GS; Zheng B; Qin Y; Zhou J; Yang Z; Zhang XH; Zhao HY; Yang HJ; Wen JK
    Theranostics; 2020; 10(17):7787-7811. PubMed ID: 32685020
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-muscle myosin II is an independent predictor of overall survival for cystectomy candidates with early-stage bladder cancer.
    Xiong D; Ye YL; Chen MK; Qin ZK; Li MZ; Zhang H; Xu LH; Xu ZZ; Zeng MS
    Oncol Rep; 2012 Nov; 28(5):1625-32. PubMed ID: 22895805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase Cgamma regulates myosin IIB phosphorylation, cellular localization, and filament assembly.
    Rosenberg M; Ravid S
    Mol Biol Cell; 2006 Mar; 17(3):1364-74. PubMed ID: 16394101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oncoprotein HBXIP promotes glucose metabolism reprogramming via downregulating SCO2 and PDHA1 in breast cancer.
    Liu F; Zhang W; You X; Liu Y; Li Y; Wang Z; Wang Y; Zhang X; Ye L
    Oncotarget; 2015 Sep; 6(29):27199-213. PubMed ID: 26309161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.